Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

NCT06423326 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Borderline Resectable Pancreatic Ductal Adenocarcinoma
Resectable Pancreatic Adenocarcinoma
Stage I Pancreatic Cancer AJCC v8
Stage II Pancreatic Cancer AJCC v8
Stage III Pancreatic Cancer AJCC v8

Interventions

PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
DRUG: Cisplatin
PROCEDURE: Computed Tomography
DRUG: Gemcitabine
PROCEDURE: Magnetic Resonance Imaging
DRUG: Nab-paclitaxel
PROCEDURE: Pancreatic Surgical Procedure

Sponsor

Emory University

Collaborators

[object Object]
[object Object]